BactiQuant A/S
BACTIQ.CO · CPH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.31 | 0.34 | -6.57 | -0.01 |
| FCF Yield | -16.25% | -17.59% | -13.60% | -8.82% |
| EV / EBITDA | -7.66 | -4.14 | -10.13 | -13.33 |
| Quality | ||||
| ROIC | -110.16% | -47.04% | -67.75% | -56.56% |
| Gross Margin | -161.42% | -6.14% | -103.23% | -142.97% |
| Cash Conversion Ratio | 0.92 | 0.62 | 1.25 | 1.04 |
| Growth | ||||
| Revenue 3-Year CAGR | -16.64% | 13.75% | 31.23% | 13.92% |
| Free Cash Flow Growth | -49.04% | 51.27% | -15.61% | -21,397.81% |
| Safety | ||||
| Net Debt / EBITDA | -0.85 | 0.30 | -0.17 | 0.71 |
| Interest Coverage | -8.78 | -7.17 | -19.52 | -15.33 |
| Efficiency | ||||
| Inventory Turnover | 4.32 | 3.51 | 7.39 | 6.77 |
| Cash Conversion Cycle | 220.10 | 116.97 | 231.72 | 117.92 |